Switch to:

# EV-to-EBITDA

: (As of Today)
View and export this data going back to 1990. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, 's enterprise value is \$0.00 Mil. does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate 's EV-to-EBITDA at this moment.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2019-12-13), 's stock price is \$. does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate 's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

## EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

 Annual Data EV-to-EBITDA

 Semi-Annual Data EV-to-EBITDA

## EV-to-EBITDA Calculation

's EV-to-EBITDA for today is calculated as:

 EV-to-EBITDA = Enterprise Value (Today) / EBITDA (TTM) = / =

(:) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

's PE Ratio for today is calculated as:

 PE Ratio = Share Price (Today) / Earnings per Share (Diluted) (TTM) = / =

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

## EV-to-EBITDA Related Terms

From GuruFocus

###### Theranexus and Beyond Batten Disease Foundation (BBDF) announce the signing of a worldwide exclusive license for Batten disease drug candidate BBDF-101

By [email protected] about 2019-12-12 18:00:12

###### Dividend and Income Fund Increases Quarterly Distribution Amount and Declares Quarterly Distributions for Each Quarter of 2020

By [email protected] about 2019-12-12 16:00:07

###### Foxby Corp. Declares Distribution

By [email protected] about 2019-12-12 16:00:05

###### Golden Dawn Provides a Business Status Update

By [email protected] about 2019-12-12 14:00:04

###### Stabilis Energy Expands Mexican Presence with Opening of LNG Transportation Hub in Northeastern Mexico

By [email protected] about 2019-12-12 14:00:04

###### Nadcap Merit Status Awarded to Oerlikon Metco Coatings GmbH

By [email protected] about 2019-12-12 10:00:04

###### Molecular Partners’ R&D Day in New York City highlights pipeline progress of DARPin(R) therapeutic candidates and provides updates on research activities

By [email protected] about 2019-12-12 01:00:01

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)
/* */